These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

854 related items for PubMed ID: 20818104

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In vitro activity of ertapenem and other carbapenems against extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae clinical isolates in a tertiary care center in Turkey.
    Kiremitci A, Dinleyici EC, Erben N, Durmaz G, Yargic ZA, Aybey AD, Usluer G.
    Expert Opin Pharmacother; 2008 Jun; 9(9):1441-9. PubMed ID: 18518776
    [Abstract] [Full Text] [Related]

  • 4. Extended spectrum beta-lactamase and metallo beta-lactamase production among Escherichia coli and Klebsiella pneumoniae isolated from different clinical samples in a tertiary care hospital in Kathmandu, Nepal.
    Nepal K, Pant ND, Neupane B, Belbase A, Baidhya R, Shrestha RK, Lekhak B, Bhatta DR, Jha B.
    Ann Clin Microbiol Antimicrob; 2017 Sep 19; 16(1):62. PubMed ID: 28927454
    [Abstract] [Full Text] [Related]

  • 5. Prevalence and antimicrobial susceptibility of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a general hospital.
    Kader AA, Kumar A.
    Ann Saudi Med; 2005 Sep 19; 25(3):239-42. PubMed ID: 16119526
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Occurrence and phenotypic detection of class A carbapenemases among Escherichia coli and Klebsiella pneumoniae blood isolates at a tertiary care center.
    Gupta V, Bansal N, Singla N, Chander J.
    J Microbiol Immunol Infect; 2013 Apr 19; 46(2):104-8. PubMed ID: 22541536
    [Abstract] [Full Text] [Related]

  • 10. The prevalence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae among clinical isolates from a general hospital in Iran.
    Bazzaz BS, Naderinasab M, Mohamadpoor AH, Farshadzadeh Z, Ahmadi S, Yousefi F.
    Acta Microbiol Immunol Hung; 2009 Mar 19; 56(1):89-99. PubMed ID: 19388560
    [Abstract] [Full Text] [Related]

  • 11. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
    Zarakolu P, Metan G, Hasçelik G, Akova M.
    Mikrobiyol Bul; 2007 Oct 19; 41(4):579-84. PubMed ID: 18173077
    [Abstract] [Full Text] [Related]

  • 12. Dramatic rise in the proportion of ESBL-producing Escherichia coli and Klebsiella pneumoniae among clinical isolates identified in Canadian hospital laboratories from 2007 to 2016.
    Denisuik AJ, Karlowsky JA, Adam HJ, Baxter MR, Lagacé-Wiens PRS, Mulvey MR, Hoban DJ, Zhanel GG, Canadian Antimicrobial Resistance Alliance (CARA) and CANWARD.
    J Antimicrob Chemother; 2019 Aug 01; 74(Suppl 4):iv64-iv71. PubMed ID: 31505647
    [Abstract] [Full Text] [Related]

  • 13. Ertapenem susceptibility of extended spectrum beta-lactamase-producing organisms.
    Mody RM, Erwin DP, Summers AM, Carrero HA, Selby EB, Ewell AJ, Moran KA.
    Ann Clin Microbiol Antimicrob; 2007 Jun 06; 6():6. PubMed ID: 17553151
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Phenotypic confirmation of extended-spectrum B-lactamases (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center.
    Del Carmen Rodríguez M, Vera DE, Ramírez-Ronda CH, Saavedra S.
    P R Health Sci J; 2004 Sep 06; 23(3):207-15. PubMed ID: 15631176
    [Abstract] [Full Text] [Related]

  • 16. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: insights from a tertiary hospital in Southern Thailand.
    Romyasamit C, Sornsenee P, Kawila S, Saengsuwan P.
    Microbiol Spectr; 2024 Jul 02; 12(7):e0021324. PubMed ID: 38809095
    [Abstract] [Full Text] [Related]

  • 17. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.
    Cho YH, Jung SI, Chung HS, Yu HS, Hwang EC, Kim SO, Kang TW, Kwon DD, Park K.
    Int Urol Nephrol; 2015 Jul 02; 47(7):1059-66. PubMed ID: 26026972
    [Abstract] [Full Text] [Related]

  • 18. Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients.
    Zhang H, Yang Q, Liao K, Ni Y, Yu Y, Hu B, Sun Z, Huang W, Wang Y, Wu A, Feng X, Luo Y, Chu Y, Chen S, Cao B, Su J, Duan Q, Zhang S, Shao H, Kong H, Gui B, Hu Z, Badal R, Xu Y.
    BMC Infect Dis; 2017 Dec 18; 17(1):776. PubMed ID: 29254478
    [Abstract] [Full Text] [Related]

  • 19. Nosocomial and community infections due to class A extended-spectrum β-lactamase (ESBLA)-producing Escherichia coli and Klebsiella spp. in southern Brazil.
    Wollheim C, Guerra IM, Conte VD, Hoffman SP, Schreiner FJ, Delamare AP, Barth AL, Echeverrigaray S, Costa SO.
    Braz J Infect Dis; 2011 Dec 18; 15(2):138-43. PubMed ID: 21503400
    [Abstract] [Full Text] [Related]

  • 20. Extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae isolated in a rural hospital.
    Basak S, Mallick SK, Bose S.
    J Indian Med Assoc; 2009 Dec 18; 107(12):855-8. PubMed ID: 20509468
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.